| Condition or disease | Intervention/treatment |
|---|---|
| Stroke TIA | Behavioral: Dedicated stroke nurse care in ED |
An intervention study comprised of 1) a primary registry database component and 2) a secondary questionnaire based quantitative evaluation . The intervention study includes a 3-month baseline observational period followed by a 7-month baseline data collection period, a 2-month intervention implementation phase, and a 3-month intervention observational period followed by 7-month intervention data collection period.
An intervention, where dedicated stroke nurses handle acute care of stroke and TIA patient in the ED prior to admission to a dedicated stroke unit will take place in the timeframe of 11-19:00 hrs, 7 days a week. Notably, the intervention is set to be integrated into clinical practice on a permanent basis after end of study.
Data for all stroke patients admitted to the ED at HGH are collected during the 3-month baseline and intervention observational periods. Fulfilment of Danish Stroke Quality Program (DAP) quality indicators is monitored as follows - use of dysphagia screen (GUSS), mobilization within day of ED admission and transfer to SU. Additional nursing interventions monitored in the ED are: Use of nasogastric catheter, use of bladder scan and intermittent catheterization, frequency of temperature monitoring and use of anti-pyretics, acute phase monitoring of blood-pressure every 2 hours, use of Scandinavian Stroke Scale (SSS) score.
Outcomes are monitored in hospital and at visits to the out patient clinic, as well as by registry.
| Study Type : | Observational |
| Estimated Enrollment : | 800 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Official Title: | Specialized Stroke Unit Nursing Interventions in the Emergency Department and Their Efficacy on Outcomes and Patient Perceptions of Clinical Care Pathway Coherence |
| Actual Study Start Date : | September 28, 2018 |
| Estimated Primary Completion Date : | September 21, 2021 |
| Estimated Study Completion Date : | November 1, 2021 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Baseline period
Usual care. Stroke patients admitted to the ED during the 3-month baseline inclusion period.
|
Behavioral: Dedicated stroke nurse care in ED
A specialized SU nursing team partner with ED nursing staff for timely fulfillment of stroke quality care indicators while awationg admission to a dedicated stroke unit
|
|
Intervention period
Intervention: 2 month implementation period of specialized stroke nurses allocated to ED for nurse specific treatment of stroke patients specific observations and care
|
Behavioral: Dedicated stroke nurse care in ED
A specialized SU nursing team partner with ED nursing staff for timely fulfillment of stroke quality care indicators while awationg admission to a dedicated stroke unit
|
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
All patients admitted with a diagnosis of acute stroke or TIA and candidate to specific stroke observation within the following 24 hours minimum.
Data for all stroke/TIA patients admitted to the ED at HGH are retrieved during the 3-month baseline and a 3 month intervention observational period during admission and at regular clinical follow-up.
Inclusion Criteria:
Exclusion criteria:
| Denmark | |
| Department of Neurology, Herlev-Gentofte Hospital | |
| Herlev, Denmark, 2730 | |
| Principal Investigator: | Christina Kruuse, MD, DMSc | Department of Neurology, Herlev-Gentofte Hospital |
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Submitted Date | October 20, 2018 | ||||
| First Posted Date | July 8, 2019 | ||||
| Last Update Posted Date | April 28, 2021 | ||||
| Actual Study Start Date | September 28, 2018 | ||||
| Estimated Primary Completion Date | September 21, 2021 (Final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures |
Incidence of infections [ Time Frame: 7 days from admission ] Incidence of pneumonia and urinary tract infections defined by a combination of clinical symptoms and para-clinical tests.
|
||||
| Original Primary Outcome Measures | Same as current | ||||
| Change History | |||||
| Current Secondary Outcome Measures |
|
||||
| Original Secondary Outcome Measures |
|
||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title | Querying Stroke Unit Nursing Interventions in the Emergency Department | ||||
| Official Title | Specialized Stroke Unit Nursing Interventions in the Emergency Department and Their Efficacy on Outcomes and Patient Perceptions of Clinical Care Pathway Coherence | ||||
| Brief Summary | The aim of the study is to monitor if specialized stroke nurses as team partners in the ED can reduce hospital acquired infections. The study is designed as pre- post-intervention study in which specialized SU nurses partner with ED nursing staff to asses and screen stroke admissions in the ED. | ||||
| Detailed Description |
An intervention study comprised of 1) a primary registry database component and 2) a secondary questionnaire based quantitative evaluation . The intervention study includes a 3-month baseline observational period followed by a 7-month baseline data collection period, a 2-month intervention implementation phase, and a 3-month intervention observational period followed by 7-month intervention data collection period. An intervention, where dedicated stroke nurses handle acute care of stroke and TIA patient in the ED prior to admission to a dedicated stroke unit will take place in the timeframe of 11-19:00 hrs, 7 days a week. Notably, the intervention is set to be integrated into clinical practice on a permanent basis after end of study. Data for all stroke patients admitted to the ED at HGH are collected during the 3-month baseline and intervention observational periods. Fulfilment of Danish Stroke Quality Program (DAP) quality indicators is monitored as follows - use of dysphagia screen (GUSS), mobilization within day of ED admission and transfer to SU. Additional nursing interventions monitored in the ED are: Use of nasogastric catheter, use of bladder scan and intermittent catheterization, frequency of temperature monitoring and use of anti-pyretics, acute phase monitoring of blood-pressure every 2 hours, use of Scandinavian Stroke Scale (SSS) score. Outcomes are monitored in hospital and at visits to the out patient clinic, as well as by registry. |
||||
| Study Type | Observational | ||||
| Study Design | Observational Model: Case-Control Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Probability Sample | ||||
| Study Population |
All patients admitted with a diagnosis of acute stroke or TIA and candidate to specific stroke observation within the following 24 hours minimum. Data for all stroke/TIA patients admitted to the ED at HGH are retrieved during the 3-month baseline and a 3 month intervention observational period during admission and at regular clinical follow-up. |
||||
| Condition |
|
||||
| Intervention | Behavioral: Dedicated stroke nurse care in ED
A specialized SU nursing team partner with ED nursing staff for timely fulfillment of stroke quality care indicators while awationg admission to a dedicated stroke unit
|
||||
| Study Groups/Cohorts |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status | Active, not recruiting | ||||
| Estimated Enrollment |
800 | ||||
| Original Estimated Enrollment | Same as current | ||||
| Estimated Study Completion Date | November 1, 2021 | ||||
| Estimated Primary Completion Date | September 21, 2021 (Final data collection date for primary outcome measure) | ||||
| Eligibility Criteria |
Inclusion Criteria:
Exclusion criteria:
|
||||
| Sex/Gender |
|
||||
| Ages | Child, Adult, Older Adult | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
| Listed Location Countries | Denmark | ||||
| Removed Location Countries | |||||
| Administrative Information | |||||
| NCT Number | NCT04011514 | ||||
| Other Study ID Numbers | H-17035544 | ||||
| Has Data Monitoring Committee | No | ||||
| U.S. FDA-regulated Product |
|
||||
| IPD Sharing Statement |
|
||||
| Responsible Party | Christina Kruuse, Herlev Hospital | ||||
| Study Sponsor | Herlev Hospital | ||||
| Collaborators | University of Copenhagen | ||||
| Investigators |
|
||||
| PRS Account | Herlev Hospital | ||||
| Verification Date | January 2021 | ||||